Company / Revenue
TELA Bio, Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$58.5M
FY2025
5-year range
$15.4M / $58.5M
FY2021-FY2025
Trend
+41.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 6 consecutive years, from $4M in FY2019 to $58M in FY2025.
Based on SEC 10-K filings.
$58M in FY2025 with a 5-year CAGR of +47.8%.
Improved from $29M to $58M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +47.5%
- 5-Year CAGR
- +47.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- TELA Bio, Inc.'s revenue has grown for 6 consecutive years.
- 5-year CAGR of +47.8%, indicating consistent growth.
- In FY2025, revenue increased 41.1% year-over-year.
- Lowest revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $58.5M | +41.1% |
| FY2024 | $41.4M | +40.6% |
| FY2023 | $29.5M | +61.8% |
| FY2022 | $18.2M | +17.9% |
| FY2021 | $15.4M | +86.7% |
| FY2020 | $8.3M | +94.9% |
| FY2019 | $4.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026